This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jun;12(6):311.

doi: 10.1038/nrclinonc.2015.60. Epub 2015 Mar 24.

Immunotherapy: Soluble ligands--a new approach to cancer therapy

PMID: 25801813
DOI: 10.1038/nrclinonc.2015.60

Comment

Immunotherapy: Soluble ligands--a new approach to cancer therapy

Alessia Errico. Nat Rev Clin Oncol. 2015 Jun.

. 2015 Jun;12(6):311.

doi: 10.1038/nrclinonc.2015.60. Epub 2015 Mar 24.

Author

PMID: 25801813
DOI: 10.1038/nrclinonc.2015.60

No abstract available

PubMed Disclaimer

Comment on

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
Deng W, Gowen BG, Zhang L, Wang L, Lau S, Iannello A, Xu J, Rovis TL, Xiong N, Raulet DH. Deng W, et al. Science. 2015 Apr 3;348(6230):136-9. doi: 10.1126/science.1258867. Epub 2015 Mar 5. Science. 2015. PMID: 25745066 Free PMC article.

Similar articles

Immunology. MULT1plying cancer immunity.
Steinle A, Cerwenka A. Steinle A, et al. Science. 2015 Apr 3;348(6230):45-6. doi: 10.1126/science.aaa9842. Science. 2015. PMID: 25838370 No abstract available.
Distinct mechanisms of tumor resistance to NK killing: of mice and men.
Pardoll DM. Pardoll DM. Immunity. 2015 Apr 21;42(4):605-6. doi: 10.1016/j.immuni.2015.04.007. Immunity. 2015. PMID: 25902479 Free PMC article.
Shed NKG2D ligand boosts NK cell immunity.
Narni-Mancinelli E, Vivier E. Narni-Mancinelli E, et al. Cell Res. 2015 Jun;25(6):651-2. doi: 10.1038/cr.2015.41. Epub 2015 Apr 7. Cell Res. 2015. PMID: 25849247 Free PMC article.
Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Chitadze G, et al. Scand J Immunol. 2013 Aug;78(2):120-9. doi: 10.1111/sji.12072. Scand J Immunol. 2013. PMID: 23679194 Review.
The role of microRNAs in the control of innate immune response in cancer.
Jasinski-Bergner S, Mandelboim O, Seliger B. Jasinski-Bergner S, et al. J Natl Cancer Inst. 2014 Sep 12;106(10):dju257. doi: 10.1093/jnci/dju257. Print 2014 Oct. J Natl Cancer Inst. 2014. PMID: 25217579 Review.

See all similar articles

References

1. Science. 2015 Apr 3;348(6230):136-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.